内镜逆行胰胆管造影术后胰腺炎的研究进展

Advances in Study on Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

胰腺炎是内镜逆行胰胆管造影术(ERCP)的术后常见并发症。ERCP患者的选择和术前评估相关危险因素是预防ERCP术后胰腺炎(PEP)的关键。胰管支架对预防PEP有一定作用,但具有局限性。NSAIDs直肠给药是降低PEP发生率的有效方式。其余药物预防PEP的结论尚不明确。本文就PEP的研究进展作一综述。

Pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography（ ERCP）. Patient selection and risk factors assessment are critical elements for preventing post-ERCP pancreatitis（PEP）. Pancreatic stent plays a role in prevention of PEP,but with limitations. Rectal administration of NSAIDs is an effective way to reduce the incidence of PEP. Effect of other drugs for preventing PEP is unclear. This article reviewed the advances in study on PEP.